CG
ABMD

Cutler Group’s Abiomed Inc ABMD Stock Holding History

Cutler Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,900
Closed -$315K – 4880
2019
Q4 		$324K Buy
+1,900
New +$352K 0.02% 617
2018
Q2 		– Sell
-200
Closed -$72.5K – 5125
2018
Q1 		$58K Buy
+200
New +$50.7K 0.01% 1562
2017
Q4 		– Sell
-2,526
Closed -$472K – 6249
2017
Q3 		$425K Buy
2,526
+1,609
+175% +$243K 0.02% 735
2017
Q2 		$131K Buy
917
+214
+30% +$28.8K ﹤0.01% 1636
2017
Q1 		$88K Sell
703
-3,811
-84% -$442K ﹤0.01% 1863
2016
Q4 		$508K Sell
4,514
-2,312
-34% -$268K 0.02% 681
2016
Q3 		$877K Buy
6,826
+4,537
+198% +$543K 0.04% 381
2016
Q2 		$250K Sell
2,289
-8,503
-79% -$846K 0.01% 962
2016
Q1 		$1.02M Buy
10,792
+4,238
+65% +$358K 0.07% 253
2015
Q4 		$591K Buy
+6,554
New +$556K 0.03% 544

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cutler Group's ABMD Position: Q1 2020 in Review

Cutler Group sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 1,900 shares — an estimated $315K sold.

Cutler Group first reported a position in ABMD in Q4 2015 and held it in 10 quarters. The position peaked at $1.02M in Q1 2016. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Cutler Group reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 1,900 Abiomed Inc shares in Q1 2020, an estimated $315K.
  • Cutler Group first reported a position in Abiomed Inc in Q4 2015 and held it in 10 quarters.
  • Cutler Group's Abiomed Inc position peaked at $1.02M in Q1 2016.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.